Nanotechnology Now - Press Release: "Endomagnetics Selected for Britain Showcase "

Home > Press > Endomagnetics Selected for Britain Showcase

Abstract:
Endomagnetics has been selected to represent the excellence of British business in a Life Sciences Sector Summit on 2nd August. Endomagnetics will be demonstrating its products at the British Business Embassy at Lancaster House, where businesses from all over the world will come together to see British innovation and to discuss opportunities for collaboration and supply. In Endomagnetics' case, clinicians and hospital administrators will be eager to see how magnetic sensing technology can make a major difference in extending the availability of key cancer staging techniques.

Endomagnetics Selected for Britain Showcase

Cambridge, MA | Posted on June 19th, 2012

During the six weeks of the 2012 Games, the British Business Embassy will host 18 days of global business summits and a Global Investment Conference, which will be one of the largest Britain has ever seen. The programme is being run by UK Trade & Investment, and is expected over time to generate Ł1 billion of additional revenue for the economy.

Prime Minister David Cameron has said: "This summer's Olympics will put the eyes of the world on Britain as we host not just an unparalleled sporting spectacle, but also a chance for companies from across the globe to interact and do business here in the UK.

"A wide range of British companies will be involved alongside the world's leading business figures in this exciting programme of events…"

Endomagnetics CEO Dr Eric Mayes said: "We are delighted and honoured to have been selected to represent British excellence in these important showcase opportunities. Our technology has clear global potential, and we look forward to forging new relationships."

The British Business Embassy forms the centrepiece of the Government's Olympic legacy strategy and will run a programme of conferences, events and networking opportunities starting at the end of July.

####

About Endomagnetics
Endomagnetics was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. Endomagnetics is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston.

The company’s first product, the SentiMag®, is an ultrasensitive hand-held probe for tracking injected Sienna+™ nanoscale magnetic materials in the human body. Cambridge, UK-based Endomagnetics is in the process of delivering its technology to global markets. For more information please visit www.endomagnetics.com.

About the British Business Initiative

The British Business Club is an online, one-stop-shop that provides up to date details of networking events, business activity, news and potential partners around international sports events, boosting the opportunities for UK companies to make valuable international business connections. The British Business Club is a partnership between UK Trade & Investment, London & Partners, London Business Network and BIS.

UK Trade & Investment (UKTI) is the government department that helps UK-based companies succeed in the global economy. UKTI also helps overseas companies bring their high quality investment to the UK’s economy - acknowledged as Europe’s best place from which to succeed in global business. UKTI offers expertise and contacts through its extensive network of specialists in the UK, and in British embassies and other diplomatic offices around the world.

For more on the British Business Initiative:

www.ukti.gov.uk/export/sectors/globalsportsprojects/item/253340.html

For more information, please click here

Contacts:
Editorial contact:
Terry Nicklin
KeynotePR Ltd
Tel: +44 (0)7923 540695

Company contact:
Dr Eric Mayes
CEO
Endomagnetics Ltd
Tel: +44 (0)1223 437131

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: